| Serum 25 (OH)D concentrations (nmol/L) |  | |||||
---|---|---|---|---|---|---|---|
All | ≥75.0 | 50.0-74.9 | 25.0-49.9 | <25.0 | P-value | ||
N (%) | 19,500 (100.00) | 6796 (34.85) | 6993 (35.86) | 4993 (25.61) | 718 (3.68) | Â | |
Gender (%) | Â | Â | Â | Â | Â | <0.001 | |
 Male | 9244 (47.41) | 3035 (44.66) | 3603 (51.52) | 2326 (46.59) | 280 (39.00) |  | |
 Female | 10,256 (52.59) | 3761 (55.34) | 3390 (48.48) | 2667 (53.41) | 438 (61.00) |  | |
Age (years), mean (SD) | 58.8 (16.26) | 62.4 (15.65) | 58.2 (16.14) | 55.3 (16.30) | 54.2 (15.77) | <0.001 | |
Race (%) | Â | Â | Â | Â | Â | 0.000 | |
 Mexican American | 2650 (13.59) | 552 (8.12) | 1119 (16.00) | 897 (17.97) | 82 (11.42) |  | |
 Non-Hispanic White | 9125 (46.79) | 4387 (64.55) | 3337 (47.72) | 1286 (25.76) | 115 (16.02) |  | |
 Non-Hispanic Black | 4688 (24.04) | 888 (13.07) | 1364 (19.51) | 1998 (40.02) | 438 (61.00) |  | |
 Other Race | 3037 (15.57) | 969 (14.26) | 1173 (16.77) | 812 (16.26) | 83 (11.56) |  | |
Education (%) | Â | Â | Â | Â | Â | <0.001 | |
 Less than high school | 5606 (28.79) | 1528 (22.52) | 2148 (30.76) | 1711 (34.32) | 219 (30.54) |  | |
 High school or equivalent | 4723 (24.26) | 1719 (25.34) | 1649 (23.61) | 1178 (23.63) | 177 (24.69) |  | |
 College or above | 9142 (46.95) | 3537 (52.14) | 3187 (45.63) | 2097 (42.06) | 321 (44.77) |  | |
PIR (%) | Â | Â | Â | Â | Â | <0.001 | |
 <1.30 | 5651 (31.56) | 1593 (25.45) | 2020 (31.40) | 1761 (38.70) | 277 (41.91) |  | |
 1.30–3.49 | 6991 (39.05) | 2473 (39.51) | 2520 (39.17) | 1735 (38.13) | 263 (39.79) |  | |
 ≥3.50 | 5261 (29.39) | 2193 (35.04) | 1893 (29.43) | 1054 (23.16) | 121 (18.31) |  | |
BMI (%) | Â | Â | Â | Â | Â | <0.001 | |
 <25.0 | 4332 (22.75) | 1898 (28.51) | 1429 (20.93) | 894 (18.37) | 111 (16.16) |  | |
 25.0-29.9 | 6242 (32.79) | 2363 (35.50) | 2332 (34.15) | 1379 (28.34) | 168 (24.45) |  | |
 ≥30.0 | 8465 (44.46) | 2396 (35.99) | 3068 (44.93) | 2593 (53.29) | 408 (59.39) |  | |
Examination month (%) | Â | Â | Â | Â | Â | <0.001 | |
 November 1 through April 30 | 9173 (47.04) | 2686 (39.52) | 3224 (46.10) | 2816 (56.40) | 447 (62.26) |  | |
 May 1 through October 31 | 10,327 (52.96) | 4110 (60.48) | 3769 (53.90) | 2177 (43.60) | 271 (37.74) |  | |
Smoking (%) | Â | Â | Â | Â | Â | <0.001 | |
 Never smoker | 9869 (50.65) | 3431 (50.52) | 3553 (50.85) | 2545 (51.02) | 340 (47.35) |  | |
 Ever smoker | 3682 (18.90) | 981 (14.45) | 1279 (18.31) | 1200 (24.06) | 222 (30.92) |  | |
 Current smoker | 5933 (30.45) | 2379 (35.03) | 2155 (30.84) | 1243 (24.92) | 156 (21.73) |  | |
Drinking (%) | Â | Â | Â | Â | Â | <0.001 | |
 Nondrinker | 6279 (40.44) | 2194 (39.83) | 2194 (39.85) | 1665 (42.24) | 226 (39.58) |  | |
 Low-to-moderate drinker | 4787 (30.83) | 1937 (35.17) | 1714 (31.14) | 1016 (25.77) | 120 (21.02) |  | |
 Heavy drinker | 4460 (28.73) | 1377 (25.00) | 1597 (29.01) | 1261 (31.99) | 225 (39.40) |  | |
Duration of hypertension (%) | Â | Â | Â | Â | Â | <0.001 | |
 ≤3 years | 2724 (24.29) | 843 (20.64) | 962 (26.62) | 804 (29.30) | 115 (23.47) |  | |
 4–10 years | 2761 (25.25) | 935 (22.89) | 968 (26.78) | 729 (26.57) | 129 (26.33) |  | |
 >10 years | 5448 (49.83) | 2307 (56.47) | 1684 (46.60) | 1211 (44.13) | 246 (50.20) |  | |
Antihypertensive therapy (%), yes | 11,760 (87.74) | 4463 (90.71) | 4075 (87.28) | 2791 (84.50) | 431 (84.34) | <0.001 | |
The use of vitamin D dietary supplements (%) | Â | Â | Â | Â | Â | 0.000 | |
 No | 8481 (59.45) | 1578 (31.43) | 3095 (64.18) | 3278 (85.36) | 530 (90.91) |  | |
 Yes | 5785 (40.55) | 3443 (68.57) | 1727 (35.82) | 562 (14.64) | 53 (9.09) |  | |
Co-morbidities (%) | Â | Â | Â | Â | Â | Â | |
 Diabetes | 4164 (22.09) | 1368 (20.87) | 1432 (21.17) | 1161 (24.04) | 203 (28.88) | <0.001 | |
 Hypercholesterolemia | 9041 (52.03) | 3462 (55.37) | 3254 (52.55) | 2045 (47.55) | 280 (44.30) | <0.001 | |
 CVD | 3941 (20.35) | 1433 (21.23) | 1336 (19.25) | 1002 (20.20) | 170 (23.74) | 0.004 | |
 Renal failure | 1091 (5.61) | 463 (6.83) | 305 (4.37) | 278 (5.59) | 45 (6.29) | < 0.001 | |
 Cancer | 2665 (13.68) | 1275 (18.78) | 850 (12.17) | 477 (9.56) | 63 (8.79) | < 0.001 |